SEC Filing Analysis: NEPHROS INC (NEPH)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director received a routine, non-cash stock award as part of their compensation.
• Market Impact: The transaction is too small to have a material impact on the stock price or trading volume.

Company Information

Field	Value
Company	NEPHROS INC
Ticker Symbol	NEPH
CIK	0001196298
Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Insider Information

Field	Value
Name	Amron Arthur H
CIK	0001179697
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-10
Transaction Code	A
Security Type	Common Stock
Shares Involved	5,391
Price Per Share	$0.00
Total Value	$0
Shares Owned After	131,272
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.0%
Shares Transacted	5,391
% of Shares Outstanding	0.051%
Post-Transaction Ownership	131,272 shares (1.24% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value is $0, making it immaterial against the company's $50 million market capitalization.
• Ownership Concentration: The director's ownership increases to 1.24% of shares outstanding, which is a minor holding.
• Dilution Impact: The grant of 5,391 shares represents a minor dilution of 0.051% to existing shareholders, which is not significant.
• Transaction Significance: Based on the negligible percentage of market cap and shares outstanding, this transaction is considered routine and has low significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Stock grants are a common form of non-cash compensation for directors and typically do not influence market sentiment or stock price.

Volume & Sentiment

• Expected Volume Impact: None. As a non-market transaction, it will not directly affect trading volume.
• Sentiment Indicator: Neutral. This is a standard corporate governance event.

Additional Context

Transaction Notes

• Special Circumstances: The transaction is an award (Code 'A') with a price of $0, confirming it is a grant and not an open market purchase. The filing also discloses derivative holdings (stock options) with vesting schedules, which are separate from this transaction.